FF
ONC

FourThought Financial’s BeOne Medicines Ltd ONC Stock Holding History

FourThought Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$6K Hold
48
– – ﹤0.01% 1158
2022
Q2 		$8K Hold
48
– – ﹤0.01% 1080
2022
Q1 		$9K Buy
48
+6
+14% +$1.28K ﹤0.01% 1071
2021
Q4 		$11K Hold
42
– – ﹤0.01% 1063
2021
Q3 		$15K Hold
42
– – ﹤0.01% 1018
2021
Q2 		$14K Hold
42
– – ﹤0.01% 1038
2021
Q1 		$14K Buy
42
+4
+11% +$1.32K ﹤0.01% 989
2020
Q4 		$9K Buy
+38
New +$10.5K ﹤0.01% 1052

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

FourThought Financial's ONC Position: Q3 2022 in Review

FourThought Financial held its BeOne Medicines Ltd (ONC) position steady in Q3 2022 at 48 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

FourThought Financial first reported a position in ONC in Q4 2020 and has held it in 8 quarters since. The position peaked at $15K in Q3 2021. 223 funds tracked by Wall St. Rank hold ONC as of Q3 2022.

  • FourThought Financial held 48 shares of BeOne Medicines Ltd worth $6K as of Q3 2022.
  • FourThought Financial left its BeOne Medicines Ltd share count unchanged in Q3 2022.
  • BeOne Medicines Ltd made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1158 holding.
  • FourThought Financial first reported a position in BeOne Medicines Ltd in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's BeOne Medicines Ltd position peaked at $15K in Q3 2021.
  • 223 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.